Amsterdam, the Netherlands and Chatsworth, CA, USA – Royal Philips Electronics (AEX: PHI, NYSE: PHG) announced today that it has acquired Burton Medical Products Corporation, a leading provider of specialized lighting solutions for healthcare facilities, from the Norwegian industrial group Glamox ASA. Terms of the acquisition were not disclosed.
The acquisition will enable Philips to further strengthen its position as a provider of healthcare lighting solutions and as such, the business will become a part of the Professional Luminaires business group of Philips Lighting. Commenting on the acquisition, Marc de Jong, General Manager, Professional Luminaires, said: “The acquisition of Burton will add a range of specialized medical lighting solutions to our general lighting portfolio for the healthcare segment, while building further the position of Philips as a total solutions provider to the medical profession.”
Burton is a healthcare lighting manufacturer engaged in the business of designing, manufacturing and distributing high quality exam, diagnostic and minor surgery lighting equipment. Since its inception in 1928, Burton has been known for superior quality, exceptional value, and long-lasting solutions to complex lighting issues facing physicians and healthcare professionals.
Philips is the world’s leading lighting company and is also one of the world’s largest providers of healthcare equipment.
Joon Knapen
Philips Corporate Communications
Tel: +31 20 59 77477
Email: joon.knapen@signify.com
Silvie Casanova
Philips Lighting North America Communications
Tel: +1-781-418-7928
Email: silvie.casanova@signify.com
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.